International Stem Cell CORP Earnings Per Share Diluted

Quick Answer

International Stem Cell CORP reported Earnings Per Share Diluted of $0.05 (loss) per share for the year ending 2025.

  • International Stem Cell CORP showed a decrease of -66.7% in Earnings Per Share Diluted from 2024 to 2025.
  • This data is from International Stem Cell CORP's annual report (Form 10-K), filed with the SEC on March 30, 2026.
  • XBRL data for this metric is available from 2014 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 10 years of available data (2014 to 2025), International Stem Cell CORP's Earnings Per Share Diluted has grown by 99.5%.
  • Historical annual values: Fiscal year 2025: $0.05 (loss) per share | Fiscal year 2024: $0.03 (loss) per share | Fiscal year 2023: $0.02 (loss) per share | Fiscal year 2022: $0.04 (loss) per share | Fiscal year 2021: $0.11 (loss) per share | Fiscal year 2018: $0.33 (loss) per share | Fiscal year 2017: $1.46 (loss) per share | Fiscal year 2016: $0.34 (loss) per share | Fiscal year 2015: $2.26 (loss) per share | Fiscal year 2014: $10.34 (loss) per share.
  • Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: